NR4A1 and neoplasm: Pathological assessment of breast cancer is currently based on criteria such as tumor size, lymph node and hormone receptor status, and epidermal growth factor receptor 2 (HER2) expression, but pathology alone does not accurately predict outcomes, even for patients with similar tumor characteristics.